Creatine Kinase MB (CK-MB)
| Product Name | Creatine Kinase MB Isoenzyme |
| Source | Human Heart |
| Catalogue Number | 190-25 |
| Purity | Purified (Control Grade) |
| Form | Lyophilized |
| Activity | > 25 U/mg solid (Dimension® Clinical Chemistry System) |
| Unit Definition | One unit will catalyze the transphosphorylation of one micromole of phosphate from creatine phosphate to ADP per minute at 37°C. |
| Protein | > 0.25 mg protein/mg (Coomassie) |
| Specific Activity | Report in U/mg protein |
| Isozyme Content | CK-MB: > 99% (Helena QuickGel® CK) CK-MM: < 1% CK-BB: < 1% |
| Contaminants | GOT/AST: < 1% (Dimension® Clinical Chemistry System) LDH: < 1% Ammonia: < 0.1 micromole/mg solid |
| Formulation | Lyophilized from 10 mM tris-succinate with 2 mM EDTA and 2 mM DTT, pH 7.5. |
| Reconstitution | Tris buffered saline with 1% BSA, 1 mM DTT and 1 mM EDTA. |
| Appearance | Light yellow to tan powder. |
| Recertification | 3 years |
| Storage | -20°C |
| Infectious Disease Testing | Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV, HBsAg, HIV-1 (NAT), HBV (NAT), HCV (NAT), and syphilis by FDA approved methods. |
| Synonyms | CKMB, CK-MB |
| Molecular Weight | 84,000 |
| CAS Number | 9001-15-4 |
| E.C. Number | 2.7.3.2 |
-
Products
- Antigens / Enzymes
- Biologicals
- Biochemicals
- Antibodies
-
Company
- Compliance
- Careers
- History
- About Us
- World Headquarters
-
Solutions
- Capabilities
- Products
- Services
-
Applications
-
Manufacturing
Research
-
Order
- How to Order
- Contact Us
- Frequent Requests
